A Controlled Trial of Early Adjunctive Treatment with Corticosteroids for<i>Pneumocystis carinii</i>Pneumonia in the Acquired Immunodeficiency Syndrome

Abstract

Early adjunctive treatment with corticosteroids reduces the risks of respiratory failure and death in patients with AIDS and moderate-to-severe pneumocystis pneumonia. Because the adverse effects are few, corticosteroids should be included as part of the initial treatment for persons with AIDS who have moderate-to-severe pneumocystis pneumonia.